INS and Hyperglycemia: Due to the hyperglycemia in diabetic patients, GOx can extensively convert glucose into gluconic acid, which results in a decreased environmental pH, and thereby the GOx-based hydrogels with pH-responsive units can undergo swelling, shrinkage, or degradation to accelerate insulin release [173].